These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 870028)

  • 21. Opiate agonists inhibit noradrenaline release via opiate B-receptors and N-cyclopropylmethylnorazidomorphine (CAM) blocks electrically evoked contractions via histamine in the mouse vas deferens.
    Knoll J; Kerecsen L; Somogyi GT; Kovács A
    Arch Int Pharmacodyn Ther; 1981 May; 251(1):52-65. PubMed ID: 6266359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide.
    Jhamandas K; Sutak M
    Br J Pharmacol; 1980; 71(1):201-10. PubMed ID: 7470736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
    Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
    J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, in vitro opiate activity, and intramolecular tyrosine--tryptophan distances of [4-tryptophan]enkephalin analogues. A reassessment of conformational models of enkephalin in solution.
    Schiller PW; St-Hilaire J
    J Med Chem; 1980 Mar; 23(3):290-4. PubMed ID: 6245213
    [No Abstract]   [Full Text] [Related]  

  • 25. Receptors for opioid peptides in the guinea-pig ileum.
    Takemori AE; Portoghese PS
    J Pharmacol Exp Ther; 1985 Nov; 235(2):389-92. PubMed ID: 2997432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opioid activity of dermenkephalin analogues in the guinea-pig myenteric plexus and the hamster vas deferens.
    Sagan S; Corbett AD; Amiche M; Delfour A; Nicolas P; Kosterlitz HW
    Br J Pharmacol; 1991 Oct; 104(2):428-32. PubMed ID: 1665735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The inhibitory effects of presynaptic alpha-adrenoceptor agonists on contractions of guinea-pig ileum and mouse vas deferens in the morphine-dependent and withdrawn states produced in vitro.
    Gillan MG; Kosterlitz HW; Robson LE; Waterfield AA
    Br J Pharmacol; 1979 Aug; 66(4):601-8. PubMed ID: 37965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel approach to demonstrate high efficacy of mu opioids in the rat vas deferens: a simple model of predictive value.
    Riba P; Friedmann T; Király KP; Al-Khrasani M; Sobor M; Asim MF; Spetea M; Schmidhammer H; Furst S
    Brain Res Bull; 2010 Jan; 81(1):178-84. PubMed ID: 19800397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-activity relationships of methionine-enkephalin.
    Morgan BA; Smith CF; Waterfield AA; Hughes J; Kosterlitz HW
    J Pharm Pharmacol; 1976 Aug; 28(8):660-1. PubMed ID: 11324
    [No Abstract]   [Full Text] [Related]  

  • 30. Opioid antagonist properties of the highly delta-receptor-selective BOC-Tyr-Pro-Gly-Phe-Leu-Thr (OtBu) peptide and of its Phe1 and Mel1 analogues.
    Rónai AZ; Magyar A; Orosz G; Borsodi A; Benyhe S; Tóth G; Makó E; Kátay E; Babka E; Medzihradszky K
    Arch Int Pharmacodyn Ther; 1995; 330(3):361-9. PubMed ID: 8836454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optically active aromatic amino acids. Part VI. Synthesis and properties of (Leu5)-enkephalin analogues containing O-methyl-L-tyrosine1 with ring substitution at position 3'.
    Arnold ZS; Schiller PW
    J Pept Sci; 2000 Jun; 6(6):280-9. PubMed ID: 10912908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross tolerance between morphine and methionine-enkephalin.
    Waterfield AA; Hughes J; Kosterlitz HW
    Nature; 1976 Apr; 260(5552):624-5. PubMed ID: 944379
    [No Abstract]   [Full Text] [Related]  

  • 33. Some pharmacological properties of a newly synthesized morphine derivative, (-)-6 beta-acetylthiomorphine.
    Takayanagi I; Konno F; Goromaru N; Koike K; Kanematsu K; Fujii I; Togame H
    Arch Int Pharmacodyn Ther; 1988; 294():71-84. PubMed ID: 3069065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional opiate receptor in mouse vas deferens: evidence for a complex interaction.
    Sánchez-Blázquez P; Garzón J; Lee NM
    J Pharmacol Exp Ther; 1983 Sep; 226(3):706-11. PubMed ID: 6310079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification of the opiate receptor from rat brain.
    Bidlack JM; Abood LG; Osei-Gyimah P; Archer S
    Proc Natl Acad Sci U S A; 1981 Jan; 78(1):636-9. PubMed ID: 6264453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of two enzyme resistant enkephalin analogs possessing enhanced analgesic activity.
    Day AR; Carney JM; Rosecrans JA; Dewey WL; Freer RJ
    Res Commun Chem Pathol Pharmacol; 1978 Apr; 20(1):59-68. PubMed ID: 663409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morphine dependence and diabetes. II. Alterations of normorphine potency in the guinea-pig ileum and mouse vas deferens and of ileal morphine dependence by changes in glucose concentration.
    Shook JE; Kachur JF; Brase DA; Dewey WL
    J Pharmacol Exp Ther; 1986 Jun; 237(3):848-52. PubMed ID: 3712282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PD117302: a selective agonist for the kappa-opioid receptor.
    Clark CR; Birchmore B; Sharif NA; Hunter JC; Hill RG; Hughes J
    Br J Pharmacol; 1988 Mar; 93(3):618-26. PubMed ID: 2836012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative structural requirements of brain neuropeptide Y binding sites and vas deferens neuropeptide Y receptors.
    Martel JC; Fournier A; St-Pierre S; Dumont Y; Forest M; Quirion R
    Mol Pharmacol; 1990 Oct; 38(4):494-502. PubMed ID: 2172766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
    Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
    Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.